IL314171A - Methods and compositions for antibody-evading virus vectors - Google Patents

Info

Publication number

IL314171A

IL314171A IL314171A IL31417124A IL314171A IL 314171 A IL314171 A IL 314171A IL 314171 A IL314171 A IL 314171A IL 31417124 A IL31417124 A IL 31417124A IL 314171 A IL314171 A IL 314171A

Authority

IL

Israel

Prior art keywords

amino acid

capsid protein

seq

aav

positions

Prior art date

2015-09-28

Links

• Espacenet
• Global Dossier
• Discuss

• 239000013598 vector Substances 0.000 title claims description 136
• 238000000034 method Methods 0.000 title claims description 47
• 239000000203 mixture Substances 0.000 title description 8
• 241001505954 Stealth virus 1 Species 0.000 title 1
• 150000001413 amino acids Chemical class 0.000 claims description 1044
• 108090000565 Capsid Proteins Proteins 0.000 claims description 565
• 102100023321 Ceruloplasmin Human genes 0.000 claims description 564
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 305
• 238000006467 substitution reaction Methods 0.000 claims description 209
• 241000702421 Dependoparvovirus Species 0.000 claims description 132
• 150000007523 nucleic acids Chemical group 0.000 claims description 74
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 24
• 239000013607 AAV vector Substances 0.000 claims description 17
• 230000010076 replication Effects 0.000 claims description 16
• 102000040430 polynucleotide Human genes 0.000 claims description 15
• 108091033319 polynucleotide Proteins 0.000 claims description 15
• 239000002157 polynucleotide Substances 0.000 claims description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
• 108020004414 DNA Proteins 0.000 claims description 7
• 238000012258 culturing Methods 0.000 claims 2
• 239000013604 expression vector Substances 0.000 claims 2
• 235000001014 amino acid Nutrition 0.000 description 1151
• 229940024606 amino acid Drugs 0.000 description 999
• 241000700605 Viruses Species 0.000 description 167
• 210000000234 capsid Anatomy 0.000 description 126
• 210000004027 cell Anatomy 0.000 description 90
• 108090000765 processed proteins & peptides Proteins 0.000 description 72
• 241001655883 Adeno-associated virus - 1 Species 0.000 description 68
• 102000039446 nucleic acids Human genes 0.000 description 63
• 108020004707 nucleic acids Proteins 0.000 description 63
• 102000004196 processed proteins & peptides Human genes 0.000 description 59
• 229920001184 polypeptide Polymers 0.000 description 50
• 230000002163 immunogen Effects 0.000 description 49
• 238000010361 transduction Methods 0.000 description 47
• 230000026683 transduction Effects 0.000 description 45
• 125000000539 amino acid group Chemical group 0.000 description 43
• 206010028980 Neoplasm Diseases 0.000 description 39
• 241000702423 Adeno-associated virus - 2 Species 0.000 description 37
• 108090000623 proteins and genes Proteins 0.000 description 37
• 241000701161 unidentified adenovirus Species 0.000 description 33
• 241001164825 Adeno-associated virus - 8 Species 0.000 description 31
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 31
• 241001634120 Adeno-associated virus - 5 Species 0.000 description 30
• 230000000890 antigenic effect Effects 0.000 description 30
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 26
• 241000972680 Adeno-associated virus - 6 Species 0.000 description 26
• 241001164823 Adeno-associated virus - 7 Species 0.000 description 24
• 241000125945 Protoparvovirus Species 0.000 description 24
• 201000011510 cancer Diseases 0.000 description 24
• 241000649045 Adeno-associated virus 10 Species 0.000 description 23
• 241000649046 Adeno-associated virus 11 Species 0.000 description 23
• 241000649047 Adeno-associated virus 12 Species 0.000 description 22
• 201000010099 disease Diseases 0.000 description 22
• 241000271566 Aves Species 0.000 description 21
• 241000283690 Bos taurus Species 0.000 description 21
• 230000010415 tropism Effects 0.000 description 21
• 239000000427 antigen Substances 0.000 description 20
• 108091007433 antigens Proteins 0.000 description 20
• 102000036639 antigens Human genes 0.000 description 20
• 230000014509 gene expression Effects 0.000 description 20
• 210000001519 tissue Anatomy 0.000 description 20
• 241000202702 Adeno-associated virus - 3 Species 0.000 description 19
• 238000003780 insertion Methods 0.000 description 19
• 230000037431 insertion Effects 0.000 description 19
• 230000004048 modification Effects 0.000 description 19
• 238000012986 modification Methods 0.000 description 19
• 239000002245 particle Substances 0.000 description 19
• -1 CAM58 Proteins 0.000 description 18
• 102000004169 proteins and genes Human genes 0.000 description 18
• 230000003612 virological effect Effects 0.000 description 18
• 210000003205 muscle Anatomy 0.000 description 17
• 235000018102 proteins Nutrition 0.000 description 17
• 230000008685 targeting Effects 0.000 description 17
• 108091030071 RNAI Proteins 0.000 description 16
• 230000009368 gene silencing by RNA Effects 0.000 description 16
• 238000006386 neutralization reaction Methods 0.000 description 16
• 241000282414 Homo sapiens Species 0.000 description 15
• 238000004806 packaging method and process Methods 0.000 description 14
• 238000003556 assay Methods 0.000 description 13
• 230000000694 effects Effects 0.000 description 13
• 230000028993 immune response Effects 0.000 description 13
• 208000015181 infectious disease Diseases 0.000 description 13
• 230000003472 neutralizing effect Effects 0.000 description 13
• 210000002027 skeletal muscle Anatomy 0.000 description 13
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 12
• 210000004185 liver Anatomy 0.000 description 12
• 210000000188 diaphragm Anatomy 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 108060001084 Luciferase Proteins 0.000 description 10
• 239000005089 Luciferase Substances 0.000 description 10
• 230000008901 benefit Effects 0.000 description 10
• 230000027455 binding Effects 0.000 description 10
• 238000012217 deletion Methods 0.000 description 10
• 230000037430 deletion Effects 0.000 description 10
• 238000001415 gene therapy Methods 0.000 description 10
• 102000005962 receptors Human genes 0.000 description 10
• 108020003175 receptors Proteins 0.000 description 10
• 210000002966 serum Anatomy 0.000 description 10
• 241001529453 unidentified herpesvirus Species 0.000 description 10
• 241000725303 Human immunodeficiency virus Species 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 238000001727 in vivo Methods 0.000 description 9
• 230000035772 mutation Effects 0.000 description 9
• 210000004165 myocardium Anatomy 0.000 description 9
• 239000000047 product Substances 0.000 description 9
• 208000024891 symptom Diseases 0.000 description 9
• 230000009885 systemic effect Effects 0.000 description 9
• 230000001225 therapeutic effect Effects 0.000 description 9
• 239000013603 viral vector Substances 0.000 description 9
• 229920002971 Heparan sulfate Polymers 0.000 description 8
• 241000713311 Simian immunodeficiency virus Species 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 238000010790 dilution Methods 0.000 description 8
• 239000012895 dilution Substances 0.000 description 8
• 230000006870 function Effects 0.000 description 8
• 230000001404 mediated effect Effects 0.000 description 8
• 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 7
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 7
• 102000004627 Iduronidase Human genes 0.000 description 7
• 108010003381 Iduronidase Proteins 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• 206010056886 Mucopolysaccharidosis I Diseases 0.000 description 7
• 108010056852 Myostatin Proteins 0.000 description 7
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
• 210000002216 heart Anatomy 0.000 description 7
• 229920000669 heparin Polymers 0.000 description 7
• 229960002897 heparin Drugs 0.000 description 7
• 230000001939 inductive effect Effects 0.000 description 7
• 230000005764 inhibitory process Effects 0.000 description 7
• 108010059929 phospholamban Proteins 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 230000002265 prevention Effects 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 6
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 230000000692 anti-sense effect Effects 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• 238000004422 calculation algorithm Methods 0.000 description 6
• 230000036039 immunity Effects 0.000 description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
• 210000003734 kidney Anatomy 0.000 description 6
• 210000004072 lung Anatomy 0.000 description 6
• 102000005681 phospholamban Human genes 0.000 description 6
• 230000001681 protective effect Effects 0.000 description 6
• 238000012546 transfer Methods 0.000 description 6
• 108010069091 Dystrophin Proteins 0.000 description 5
• 102000003951 Erythropoietin Human genes 0.000 description 5
• 108090000394 Erythropoietin Proteins 0.000 description 5
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 5
• 108010025020 Nerve Growth Factor Proteins 0.000 description 5
• 210000004556 brain Anatomy 0.000 description 5
• 230000007812 deficiency Effects 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 229940105423 erythropoietin Drugs 0.000 description 5
• 239000012634 fragment Substances 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 5
• 230000002829 reductive effect Effects 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 5
• 238000002741 site-directed mutagenesis Methods 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 238000012384 transportation and delivery Methods 0.000 description 5
• 241000712461 unidentified influenza virus Species 0.000 description 5
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
• 102400000068 Angiostatin Human genes 0.000 description 4
• 108010079709 Angiostatins Proteins 0.000 description 4
• IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical group NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 4
• 241000701931 Canine parvovirus Species 0.000 description 4
• 102000004127 Cytokines Human genes 0.000 description 4
• 108090000695 Cytokines Proteins 0.000 description 4
• 102000001039 Dystrophin Human genes 0.000 description 4
• 102400001047 Endostatin Human genes 0.000 description 4
• 108010079505 Endostatins Proteins 0.000 description 4
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• 108700019146 Transgenes Proteins 0.000 description 4
• 108020005202 Viral DNA Proteins 0.000 description 4
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
• 230000003110 anti-inflammatory effect Effects 0.000 description 4
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 238000001493 electron microscopy Methods 0.000 description 4
• 210000002889 endothelial cell Anatomy 0.000 description 4
• 239000003102 growth factor Substances 0.000 description 4
• 230000002458 infectious effect Effects 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 210000005229 liver cell Anatomy 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• 238000013507 mapping Methods 0.000 description 4
• 238000009126 molecular therapy Methods 0.000 description 4
• 239000002773 nucleotide Substances 0.000 description 4
• 125000003729 nucleotide group Chemical group 0.000 description 4
• 230000036961 partial effect Effects 0.000 description 4
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
• 239000013608 rAAV vector Substances 0.000 description 4
• 238000012216 screening Methods 0.000 description 4
• 239000007858 starting material Substances 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 241000701447 unidentified baculovirus Species 0.000 description 4
• 229960005486 vaccine Drugs 0.000 description 4
• 241000958487 Adeno-associated virus 3B Species 0.000 description 3
• 101100118004 Arabidopsis thaliana EBP1 gene Proteins 0.000 description 3
• 101150052583 CALM1 gene Proteins 0.000 description 3
• 102100025580 Calmodulin-1 Human genes 0.000 description 3
• 101100459256 Cyprinus carpio myca gene Proteins 0.000 description 3
• 201000003883 Cystic fibrosis Diseases 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• 208000024720 Fabry Disease Diseases 0.000 description 3
• 208000015872 Gaucher disease Diseases 0.000 description 3
• 102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 3
• 108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 3
• 102000004547 Glucosylceramidase Human genes 0.000 description 3
• 108010017544 Glucosylceramidase Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 description 3
• 206010053185 Glycogen storage disease type II Diseases 0.000 description 3
• 102000003886 Glycoproteins Human genes 0.000 description 3
• 108090000288 Glycoproteins Proteins 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 102000004877 Insulin Human genes 0.000 description 3
• 108090001061 Insulin Proteins 0.000 description 3
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 102000000853 LDL receptors Human genes 0.000 description 3
• 108010001831 LDL receptors Proteins 0.000 description 3
• 206010023927 Lassa fever Diseases 0.000 description 3
• 101710096786 Lysosomal acid alpha-glucosidase Proteins 0.000 description 3
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 3
• 206010048723 Multiple-drug resistance Diseases 0.000 description 3
• 102000007072 Nerve Growth Factors Human genes 0.000 description 3
• 108090000189 Neuropeptides Proteins 0.000 description 3
• 102000013275 Somatomedins Human genes 0.000 description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
• 239000004473 Threonine Substances 0.000 description 3
• 108010030291 alpha-Galactosidase Proteins 0.000 description 3
• 102000005840 alpha-Galactosidase Human genes 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 235000009697 arginine Nutrition 0.000 description 3
• UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 3
• 210000000988 bone and bone Anatomy 0.000 description 3
• 101150091339 cam-1 gene Proteins 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 230000000747 cardiac effect Effects 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 108091006104 gene-regulatory proteins Proteins 0.000 description 3
• 235000013922 glutamic acid Nutrition 0.000 description 3
• 239000004220 glutamic acid Substances 0.000 description 3
• 208000007345 glycogen storage disease Diseases 0.000 description 3
• 201000004502 glycogen storage disease II Diseases 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 229940125396 insulin Drugs 0.000 description 3
• 229940079322 interferon Drugs 0.000 description 3
• 230000002132 lysosomal effect Effects 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 239000003900 neurotrophic factor Substances 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
• 235000008729 phenylalanine Nutrition 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 230000003362 replicative effect Effects 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 210000000130 stem cell Anatomy 0.000 description 3
• 235000008521 threonine Nutrition 0.000 description 3
• 230000002463 transducing effect Effects 0.000 description 3
• 210000002845 virion Anatomy 0.000 description 3
• 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 2
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
• 108010059616 Activins Proteins 0.000 description 2
• 102000005606 Activins Human genes 0.000 description 2
• 102000055025 Adenosine deaminases Human genes 0.000 description 2
• 101100438239 Arabidopsis thaliana CAM4 gene Proteins 0.000 description 2
• 101100438241 Arabidopsis thaliana CAM5 gene Proteins 0.000 description 2
• 101100328411 Arabidopsis thaliana CML8 gene Proteins 0.000 description 2
• 239000004475 Arginine Substances 0.000 description 2
• 102100031491 Arylsulfatase B Human genes 0.000 description 2
• 101000588395 Bacillus subtilis (strain 168) Beta-hexosaminidase Proteins 0.000 description 2
• 102100026189 Beta-galactosidase Human genes 0.000 description 2
• 241000701922 Bovine parvovirus Species 0.000 description 2
• 101150026942 CAM3 gene Proteins 0.000 description 2
• 108010051834 CTTHWGFTLC peptide Proteins 0.000 description 2
• 101150058073 Calm3 gene Proteins 0.000 description 2
• 102100025926 Calmodulin-3 Human genes 0.000 description 2
• 241000282465 Canis Species 0.000 description 2
• 208000024172 Cardiovascular disease Diseases 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 102100022641 Coagulation factor IX Human genes 0.000 description 2
• 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 2
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 102000016607 Diphtheria Toxin Human genes 0.000 description 2
• 108010053187 Diphtheria Toxin Proteins 0.000 description 2
• 102000004190 Enzymes Human genes 0.000 description 2
• 108090000790 Enzymes Proteins 0.000 description 2
• 102400001368 Epidermal growth factor Human genes 0.000 description 2
• 101800003838 Epidermal growth factor Proteins 0.000 description 2
• 108010076282 Factor IX Proteins 0.000 description 2
• 108010054218 Factor VIII Proteins 0.000 description 2
• 102000001690 Factor VIII Human genes 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 102000016970 Follistatin Human genes 0.000 description 2
• 108010014612 Follistatin Proteins 0.000 description 2
• 102000006575 G-Protein-Coupled Receptor Kinases Human genes 0.000 description 2
• 108010008959 G-Protein-Coupled Receptor Kinases Proteins 0.000 description 2
• 101800002068 Galanin Proteins 0.000 description 2
• 102400001370 Galanin Human genes 0.000 description 2
• 102000053187 Glucuronidase Human genes 0.000 description 2
• 108010060309 Glucuronidase Proteins 0.000 description 2
• 101710154606 Hemagglutinin Proteins 0.000 description 2
• 208000005176 Hepatitis C Diseases 0.000 description 2
• 102000016871 Hexosaminidase A Human genes 0.000 description 2
• 108010053317 Hexosaminidase A Proteins 0.000 description 2
• 101000685712 Homo sapiens Protein S100-A1 Proteins 0.000 description 2
• 101000600434 Homo sapiens Putative uncharacterized protein encoded by MIR7-3HG Proteins 0.000 description 2
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 2
• 244000309467 Human Coronavirus Species 0.000 description 2
• 241000702617 Human parvovirus B19 Species 0.000 description 2
• 208000015178 Hurler syndrome Diseases 0.000 description 2
• 208000015204 Hurler-Scheie syndrome Diseases 0.000 description 2
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 2
• 108010053927 Iduronate Sulfatase Proteins 0.000 description 2
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 2
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 2
• 102100020872 Leucyl-cystinyl aminopeptidase Human genes 0.000 description 2
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
• 208000015439 Lysosomal storage disease Diseases 0.000 description 2
• 102100022430 Melanocyte protein PMEL Human genes 0.000 description 2
• 101710151321 Melanostatin Proteins 0.000 description 2
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 2
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 2
• 102000015728 Mucins Human genes 0.000 description 2
• 108010063954 Mucins Proteins 0.000 description 2
• 208000002678 Mucopolysaccharidoses Diseases 0.000 description 2
• 206010028095 Mucopolysaccharidosis IV Diseases 0.000 description 2
• 206010056893 Mucopolysaccharidosis VII Diseases 0.000 description 2
• 208000025915 Mucopolysaccharidosis type 6 Diseases 0.000 description 2
• 108010027520 N-Acetylgalactosamine-4-Sulfatase Proteins 0.000 description 2
• 102100031688 N-acetylgalactosamine-6-sulfatase Human genes 0.000 description 2
• 101710099863 N-acetylgalactosamine-6-sulfatase Proteins 0.000 description 2
• 102100023282 N-acetylglucosamine-6-sulfatase Human genes 0.000 description 2
• 108010023320 N-acetylglucosamine-6-sulfatase Proteins 0.000 description 2
• KSPIYJQBLVDRRI-UHFFFAOYSA-N N-methylisoleucine Chemical compound CCC(C)C(NC)C(O)=O KSPIYJQBLVDRRI-UHFFFAOYSA-N 0.000 description 2
• 108010006140 N-sulfoglucosamine sulfohydrolase Proteins 0.000 description 2
• 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 2
• 102000015336 Nerve Growth Factor Human genes 0.000 description 2
• 102400000064 Neuropeptide Y Human genes 0.000 description 2
• 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 2
• 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 2
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
• 208000018737 Parkinson disease Diseases 0.000 description 2
• 108060005874 Parvalbumin Proteins 0.000 description 2
• 102000001675 Parvalbumin Human genes 0.000 description 2
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 2
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 2
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 101710176177 Protein A56 Proteins 0.000 description 2
• 102100023097 Protein S100-A1 Human genes 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 102100037401 Putative uncharacterized protein encoded by MIR7-3HG Human genes 0.000 description 2
• 102000014128 RANK Ligand Human genes 0.000 description 2
• 108010025832 RANK Ligand Proteins 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 108010077895 Sarcosine Proteins 0.000 description 2
• 102000011265 Sarcospan Human genes 0.000 description 2
• 108050001531 Sarcospan Proteins 0.000 description 2
• 201000002883 Scheie syndrome Diseases 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 201000001828 Sly syndrome Diseases 0.000 description 2
• 102000011971 Sphingomyelin Phosphodiesterase Human genes 0.000 description 2
• 108010061312 Sphingomyelin Phosphodiesterase Proteins 0.000 description 2
• 101710172711 Structural protein Proteins 0.000 description 2
• 102000019197 Superoxide Dismutase Human genes 0.000 description 2
• 108010012715 Superoxide dismutase Proteins 0.000 description 2
• 101800001271 Surface protein Proteins 0.000 description 2
• 102220564325 TIR domain-containing adapter molecule 2_S16E_mutation Human genes 0.000 description 2
• 108700012411 TNFSF10 Proteins 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 2
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 108091026823 U7 small nuclear RNA Proteins 0.000 description 2
• 108010075653 Utrophin Proteins 0.000 description 2
• 102000011856 Utrophin Human genes 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 108020002494 acetyltransferase Proteins 0.000 description 2
• 102000005421 acetyltransferase Human genes 0.000 description 2
• 239000000488 activin Substances 0.000 description 2
• 108060000200 adenylate cyclase Proteins 0.000 description 2
• 102000030621 adenylate cyclase Human genes 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 239000004037 angiogenesis inhibitor Substances 0.000 description 2
• 229940121369 angiogenesis inhibitor Drugs 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 2
• 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 description 2
• 108010005774 beta-Galactosidase Proteins 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 210000005013 brain tissue Anatomy 0.000 description 2
• 230000015861 cell surface binding Effects 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• VEVRNHHLCPGNDU-MUGJNUQGSA-O desmosine Chemical compound OC(=O)[C@@H](N)CCCC[N+]1=CC(CC[C@H](N)C(O)=O)=C(CCC[C@H](N)C(O)=O)C(CC[C@H](N)C(O)=O)=C1 VEVRNHHLCPGNDU-MUGJNUQGSA-O 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 239000003814 drug Substances 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 229940088598 enzyme Drugs 0.000 description 2
• 229940116977 epidermal growth factor Drugs 0.000 description 2
• 206010015037 epilepsy Diseases 0.000 description 2
• 108700020302 erbB-2 Genes Proteins 0.000 description 2
• 229960004222 factor ix Drugs 0.000 description 2
• 229960000301 factor viii Drugs 0.000 description 2
• 229940126864 fibroblast growth factor Drugs 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 230000030279 gene silencing Effects 0.000 description 2
• 238000012226 gene silencing method Methods 0.000 description 2
• 102000034356 gene-regulatory proteins Human genes 0.000 description 2
• 150000002298 globosides Chemical class 0.000 description 2
• 210000002064 heart cell Anatomy 0.000 description 2
• 239000000185 hemagglutinin Substances 0.000 description 2
• 208000006454 hepatitis Diseases 0.000 description 2
• 231100000283 hepatitis Toxicity 0.000 description 2
• 208000002672 hepatitis B Diseases 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 102000006495 integrins Human genes 0.000 description 2
• 108010044426 integrins Proteins 0.000 description 2
• RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 235000018977 lysine Nutrition 0.000 description 2
• 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• 208000030159 metabolic disease Diseases 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 150000002739 metals Chemical class 0.000 description 2
• 230000000116 mitigating effect Effects 0.000 description 2
• SLZIZIJTGAYEKK-CIJSCKBQSA-N molport-023-220-247 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CN)[C@@H](C)O)C1=CNC=N1 SLZIZIJTGAYEKK-CIJSCKBQSA-N 0.000 description 2
• 230000000921 morphogenic effect Effects 0.000 description 2
• 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
• 206010028093 mucopolysaccharidosis Diseases 0.000 description 2
• 201000002273 mucopolysaccharidosis II Diseases 0.000 description 2
• 208000005340 mucopolysaccharidosis III Diseases 0.000 description 2
• 208000012253 mucopolysaccharidosis IVA Diseases 0.000 description 2
• 208000000690 mucopolysaccharidosis VI Diseases 0.000 description 2
• 208000022018 mucopolysaccharidosis type 2 Diseases 0.000 description 2
• 208000011045 mucopolysaccharidosis type 3 Diseases 0.000 description 2
• 208000010978 mucopolysaccharidosis type 4 Diseases 0.000 description 2
• 208000025919 mucopolysaccharidosis type 7 Diseases 0.000 description 2
• 229940053128 nerve growth factor Drugs 0.000 description 2
• URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 2
• 210000000496 pancreas Anatomy 0.000 description 2
• 208000030613 peripheral artery disease Diseases 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 210000001525 retina Anatomy 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 210000002460 smooth muscle Anatomy 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 238000002255 vaccination Methods 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 210000003556 vascular endothelial cell Anatomy 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• IEIMRKVTGUNYPS-RSLQBAFYSA-N (2S)-3-hydroxypyrrolidine-2-carboxylic acid (2S)-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound OC1CN[C@H](C(O)=O)C1.OC1CCN[C@@H]1C(O)=O IEIMRKVTGUNYPS-RSLQBAFYSA-N 0.000 description 1
• YWMBHAIUGXZXHT-WCCKRBBISA-N (2S)-4-amino-2-(ethylamino)-4-oxobutanoic acid 2-(ethylamino)acetic acid Chemical compound CCNCC(O)=O.CCN[C@H](C(O)=O)CC(N)=O YWMBHAIUGXZXHT-WCCKRBBISA-N 0.000 description 1
• MRTPISKDZDHEQI-YFKPBYRVSA-N (2s)-2-(tert-butylamino)propanoic acid Chemical compound OC(=O)[C@H](C)NC(C)(C)C MRTPISKDZDHEQI-YFKPBYRVSA-N 0.000 description 1
• MKSPBYRGLCNGRC-OEMOKZHXSA-N (2s)-2-[[(2s)-1-[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s,3r)-2-[[(2s)-2-aminopropanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1h-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound O=C([C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)CC(C)C)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MKSPBYRGLCNGRC-OEMOKZHXSA-N 0.000 description 1
• HOZBSSWDEKVXNO-BXRBKJIMSA-N (2s)-2-azanylbutanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CC(O)=O HOZBSSWDEKVXNO-BXRBKJIMSA-N 0.000 description 1
• AGTSSZRZBSNTGQ-ITZCFHCWSA-N (2s,3r)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomet Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 AGTSSZRZBSNTGQ-ITZCFHCWSA-N 0.000 description 1
• KBSORCBSCSOBHH-IHJZLXGESA-N (4s)-5-[(2s)-2-[[(2s)-6-amino-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin Chemical compound CC(C)[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KBSORCBSCSOBHH-IHJZLXGESA-N 0.000 description 1
• XABCFXXGZPWJQP-BYPYZUCNSA-N (S)-3-aminoadipic acid Chemical compound OC(=O)C[C@@H](N)CCC(O)=O XABCFXXGZPWJQP-BYPYZUCNSA-N 0.000 description 1
• GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
• UCWIJRLALQMQMP-UHFFFAOYSA-N 2-aminobutanoic acid;4-aminobutanoic acid Chemical compound CCC(N)C(O)=O.NCCCC(O)=O UCWIJRLALQMQMP-UHFFFAOYSA-N 0.000 description 1
• NDDZMHYTLXPYHA-UHFFFAOYSA-N 2-aminohexanedioic acid;3-aminohexanedioic acid Chemical compound OC(=O)CC(N)CCC(O)=O.OC(=O)C(N)CCCC(O)=O NDDZMHYTLXPYHA-UHFFFAOYSA-N 0.000 description 1
• LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 description 1
• QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 1
• 101800000504 3C-like protease Proteins 0.000 description 1
• BMNBFRJBYVIOAY-UHFFFAOYSA-N 4,7,8-trihydroxy-3,4-dihydro-2h-isoquinolin-2-ium-1-one;chloride Chemical compound [Cl-].OC1=CC=C2C(O)C[NH2+]C(=O)C2=C1O BMNBFRJBYVIOAY-UHFFFAOYSA-N 0.000 description 1
• QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
• 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
• OOXNYFKPOPJIOT-UHFFFAOYSA-N 5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine;dihydrochloride Chemical compound Cl.Cl.C=12C(N)=NC=NC2=NC(C=2C=NC(=CC=2)N2CCOCC2)=CC=1C1=CC=CC(Br)=C1 OOXNYFKPOPJIOT-UHFFFAOYSA-N 0.000 description 1
• SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N 5-hydroxylysine Chemical group NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 102100036464 Activated RNA polymerase II transcriptional coactivator p15 Human genes 0.000 description 1
• 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
• 241000425548 Adeno-associated virus 3A Species 0.000 description 1
• 102100032534 Adenosine kinase Human genes 0.000 description 1
• 108010076278 Adenosine kinase Proteins 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 208000031277 Amaurotic familial idiocy Diseases 0.000 description 1
• 241000702419 Ambidensovirus Species 0.000 description 1
• 108010064733 Angiotensins Proteins 0.000 description 1
• 102000015427 Angiotensins Human genes 0.000 description 1
• 101100438246 Arabidopsis thaliana CAM6 gene Proteins 0.000 description 1
• 101100438247 Arabidopsis thaliana CAM7 gene Proteins 0.000 description 1
• 241000712891 Arenavirus Species 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 102100032948 Aspartoacylase Human genes 0.000 description 1
• 108700023155 Aspartoacylases Proteins 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 102000007372 Ataxin-1 Human genes 0.000 description 1
• 108010032963 Ataxin-1 Proteins 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 1
• 108700020463 BRCA1 Proteins 0.000 description 1
• 102000036365 BRCA1 Human genes 0.000 description 1
• 102000052609 BRCA2 Human genes 0.000 description 1
• 108700020462 BRCA2 Proteins 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• 108010051479 Bombesin Proteins 0.000 description 1
• 102000013585 Bombesin Human genes 0.000 description 1
• 102400000967 Bradykinin Human genes 0.000 description 1
• 101800004538 Bradykinin Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 102100035344 Cadherin-related family member 1 Human genes 0.000 description 1
• 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
• 101100342337 Caenorhabditis elegans klf-1 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
• 101150044789 Cap gene Proteins 0.000 description 1
• 206010007559 Cardiac failure congestive Diseases 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 108090000538 Caspase-8 Proteins 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 206010050389 Cerebral ataxia Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000684559 Chicken parvovirus Species 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 229920001287 Chondroitin sulfate Polymers 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 206010010099 Combined immunodeficiency Diseases 0.000 description 1
• VPAXJOUATWLOPR-UHFFFAOYSA-N Conferone Chemical compound C1=CC(=O)OC2=CC(OCC3C4(C)CCC(=O)C(C)(C)C4CC=C3C)=CC=C21 VPAXJOUATWLOPR-UHFFFAOYSA-N 0.000 description 1
• 206010010456 Congenital emphysema Diseases 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 108700002856 Coronavirus Envelope Proteins Proteins 0.000 description 1
• 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 1
• 102000000311 Cytosine Deaminase Human genes 0.000 description 1
• 108010080611 Cytosine Deaminase Proteins 0.000 description 1
• SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 1
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 102000002322 Egg Proteins Human genes 0.000 description 1
• 108010000912 Egg Proteins Proteins 0.000 description 1
• 102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 description 1
• 108010049140 Endorphins Proteins 0.000 description 1
• 102000009025 Endorphins Human genes 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 101710144543 Endosialin Proteins 0.000 description 1
• 108010092674 Enkephalins Proteins 0.000 description 1
• 101710121417 Envelope glycoprotein Proteins 0.000 description 1
• 241000713730 Equine infectious anemia virus Species 0.000 description 1
• 241000121268 Erythroparvovirus Species 0.000 description 1
• 206010016077 Factor IX deficiency Diseases 0.000 description 1
• 201000003542 Factor VIII deficiency Diseases 0.000 description 1
• 108010014173 Factor X Proteins 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241000701925 Feline parvovirus Species 0.000 description 1
• 241000282324 Felis Species 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 102100039717 G antigen 1 Human genes 0.000 description 1
• 108010033708 GFE-1 peptide Proteins 0.000 description 1
• 101150117028 GP gene Proteins 0.000 description 1
• 101710177291 Gag polyprotein Proteins 0.000 description 1
• 102100028496 Galactocerebrosidase Human genes 0.000 description 1
• 108010042681 Galactosylceramidase Proteins 0.000 description 1
• 102000004862 Gastrin releasing peptide Human genes 0.000 description 1
• 108090001053 Gastrin releasing peptide Proteins 0.000 description 1
• 208000010055 Globoid Cell Leukodystrophy Diseases 0.000 description 1
• 102000006395 Globulins Human genes 0.000 description 1
• 108010044091 Globulins Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 102000009165 Gonadoliberin Human genes 0.000 description 1
• 108050000048 Gonadoliberin Proteins 0.000 description 1
• 241001517118 Goose parvovirus Species 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 241000702620 H-1 parvovirus Species 0.000 description 1
• QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 208000028782 Hereditary disease Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
• 101000737767 Homo sapiens Cadherin-related family member 1 Proteins 0.000 description 1
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
• 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
• 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
• 101000886137 Homo sapiens G antigen 1 Proteins 0.000 description 1
• 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
• 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
• 101000652321 Homo sapiens Protein SOX-15 Proteins 0.000 description 1
• 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 description 1
• 101000652332 Homo sapiens Transcription factor SOX-1 Proteins 0.000 description 1
• 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 description 1
• 101000687911 Homo sapiens Transcription factor SOX-3 Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• 208000023105 Huntington disease Diseases 0.000 description 1
• 206010020575 Hyperammonaemia Diseases 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 102000038455 IGF Type 1 Receptor Human genes 0.000 description 1
• 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 241000711450 Infectious bronchitis virus Species 0.000 description 1
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 208000012659 Joint disease Diseases 0.000 description 1
• 108010010994 K237 peptide Proteins 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 101150072501 Klf2 gene Proteins 0.000 description 1
• 208000028226 Krabbe disease Diseases 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• AGPKZVBTJJNPAG-UHNVWZDZSA-N L-allo-Isoleucine Chemical compound CC[C@@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-UHNVWZDZSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 1
• 101710093778 L-dopachrome tautomerase Proteins 0.000 description 1
• SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
• QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
• FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 description 1
• QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 108010092277 Leptin Proteins 0.000 description 1
• 102000016267 Leptin Human genes 0.000 description 1
• 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
• 102400000243 Leu-enkephalin Human genes 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 108010022337 Leucine Enkephalin Proteins 0.000 description 1
• 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
• 102100022119 Lipoprotein lipase Human genes 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 241000282560 Macaca mulatta Species 0.000 description 1
• 208000002569 Machado-Joseph Disease Diseases 0.000 description 1
• 101710125418 Major capsid protein Proteins 0.000 description 1
• 208000030162 Maple syrup disease Diseases 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
• 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 102400001357 Motilin Human genes 0.000 description 1
• 101800002372 Motilin Proteins 0.000 description 1
• 208000005647 Mumps Diseases 0.000 description 1
• 102000016943 Muramidase Human genes 0.000 description 1
• 108010014251 Muramidase Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 206010028289 Muscle atrophy Diseases 0.000 description 1
• 241001503699 Muscovy duck parvovirus Species 0.000 description 1
• 108091057508 Myc family Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• PQNASZJZHFPQLE-LURJTMIESA-N N(6)-methyl-L-lysine Chemical compound CNCCCC[C@H](N)C(O)=O PQNASZJZHFPQLE-LURJTMIESA-N 0.000 description 1
• OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• 108700026495 N-Myc Proto-Oncogene Proteins 0.000 description 1
• OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
• MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
• OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
• MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
• OLNLSTNFRUFTLM-BYPYZUCNSA-N N-ethyl-L-asparagine Chemical compound CCN[C@H](C(O)=O)CC(N)=O OLNLSTNFRUFTLM-BYPYZUCNSA-N 0.000 description 1
• YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 description 1
• KSPIYJQBLVDRRI-WDSKDSINSA-N N-methyl-L-isoleucine Chemical compound CC[C@H](C)[C@H](NC)C(O)=O KSPIYJQBLVDRRI-WDSKDSINSA-N 0.000 description 1
• AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical compound CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 description 1
• 102100030124 N-myc proto-oncogene protein Human genes 0.000 description 1
• URNUTSZSZXTIKI-FJXQXJEOSA-N NC(C(=O)O)CCN.C1(CCCCC1)N[C@@H](C)C(=O)O Chemical compound NC(C(=O)O)CCN.C1(CCCCC1)N[C@@H](C)C(=O)O URNUTSZSZXTIKI-FJXQXJEOSA-N 0.000 description 1
• 101150118742 NP gene Proteins 0.000 description 1
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
• 102100028782 Neprilysin Human genes 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 102000003797 Neuropeptides Human genes 0.000 description 1
• 102400001103 Neurotensin Human genes 0.000 description 1
• 101800001814 Neurotensin Proteins 0.000 description 1
• 208000014060 Niemann-Pick disease Diseases 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
• 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• RMINQIRDFIBNLE-NNRWGFCXSA-N O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-serine Chemical compound O1[C@H](OC[C@H](N)C(O)=O)[C@H](NC(=O)C)[C@@H](O)[C@@H](O)[C@H]1CO[C@@]1(C(O)=O)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C1 RMINQIRDFIBNLE-NNRWGFCXSA-N 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 241000713112 Orthobunyavirus Species 0.000 description 1
• 101100043434 Oryza sativa subsp. japonica SERR gene Proteins 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 108060006580 PRAME Proteins 0.000 description 1
• 102000036673 PRAME Human genes 0.000 description 1
• 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
• 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 102000015731 Peptide Hormones Human genes 0.000 description 1
• 108010038988 Peptide Hormones Proteins 0.000 description 1
• 201000005702 Pertussis Diseases 0.000 description 1
• 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
• 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
• 201000011252 Phenylketonuria Diseases 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 102100024266 Pneumadin Human genes 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
• 102100030244 Protein SOX-15 Human genes 0.000 description 1
• 101710149951 Protein Tat Proteins 0.000 description 1
• 102100025460 Protein lin-28 homolog A Human genes 0.000 description 1
• 229940116193 Protein phosphatase inhibitor Drugs 0.000 description 1
• 206010037075 Protozoal infections Diseases 0.000 description 1
• 108091008103 RNA aptamers Proteins 0.000 description 1
• 101710100968 Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 208000017442 Retinal disease Diseases 0.000 description 1
• 101150107345 Rhag gene Proteins 0.000 description 1
• 241000713124 Rift Valley fever virus Species 0.000 description 1
• 102400000235 Rimorphin Human genes 0.000 description 1
• 101800001440 Rimorphin Proteins 0.000 description 1
• 102000006308 Sarcoglycans Human genes 0.000 description 1
• 108010083379 Sarcoglycans Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 101710173693 Short transient receptor potential channel 1 Proteins 0.000 description 1
• 101710173694 Short transient receptor potential channel 2 Proteins 0.000 description 1
• 244000191761 Sida cordifolia Species 0.000 description 1
• 108020004682 Single-Stranded DNA Proteins 0.000 description 1
• 108091027967 Small hairpin RNA Proteins 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 108010019965 Spectrin Proteins 0.000 description 1
• 102000005890 Spectrin Human genes 0.000 description 1
• 208000009415 Spinocerebellar Ataxias Diseases 0.000 description 1
• 201000003622 Spinocerebellar ataxia type 2 Diseases 0.000 description 1
• 208000036834 Spinocerebellar ataxia type 3 Diseases 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 208000022292 Tay-Sachs disease Diseases 0.000 description 1
• 101710192266 Tegument protein VP22 Proteins 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 108010055044 Tetanus Toxin Proteins 0.000 description 1
• 208000002903 Thalassemia Diseases 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102100030248 Transcription factor SOX-1 Human genes 0.000 description 1
• 102100024270 Transcription factor SOX-2 Human genes 0.000 description 1
• 102100024276 Transcription factor SOX-3 Human genes 0.000 description 1
• 108010074506 Transfer Factor Proteins 0.000 description 1
• 108010009583 Transforming Growth Factors Proteins 0.000 description 1
• 102000009618 Transforming Growth Factors Human genes 0.000 description 1
• 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
• LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 102100021162 Tubulinyl-Tyr carboxypeptidase 2 Human genes 0.000 description 1
• 101710179228 Tubulinyl-Tyr carboxypeptidase 2 Proteins 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
• 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
• 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 1
• 108091026838 U1 spliceosomal RNA Proteins 0.000 description 1
• 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 description 1
• 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 description 1
• 108020004417 Untranslated RNA Proteins 0.000 description 1
• 102000039634 Untranslated RNA Human genes 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 1
• 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 241000710772 Yellow fever virus Species 0.000 description 1
• 101710185494 Zinc finger protein Proteins 0.000 description 1
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 201000009628 adenosine deaminase deficiency Diseases 0.000 description 1
• 108700015342 adenovirus terminal Proteins 0.000 description 1
• 210000001789 adipocyte Anatomy 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 1
• 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 1
• 229940024142 alpha 1-antitrypsin Drugs 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 150000001484 arginines Chemical class 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 108010048605 aspartyl-valyl-phenylalanyl-tyrosyl-prolyl-tyrosyl-prolyl-tyrosyl-alanyl-seryl-glycyl-serine Proteins 0.000 description 1
• 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• WTOFYLAWDLQMBZ-LURJTMIESA-N beta(2-thienyl)alanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CS1 WTOFYLAWDLQMBZ-LURJTMIESA-N 0.000 description 1
• 229940000635 beta-alanine Drugs 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
• 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000036978 cell physiology Effects 0.000 description 1
• 230000008614 cellular interaction Effects 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000012412 chemical coupling Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 229940059329 chondroitin sulfate Drugs 0.000 description 1
• 229960002173 citrulline Drugs 0.000 description 1
• 235000013477 citrulline Nutrition 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 150000001875 compounds Chemical class 0.000 description 1
• JECGPMYZUFFYJW-UHFFFAOYSA-N conferone Natural products CC1=CCC2C(C)(C)C(=O)CCC2(C)C1COc3cccc4C=CC(=O)Oc34 JECGPMYZUFFYJW-UHFFFAOYSA-N 0.000 description 1
• 210000004087 cornea Anatomy 0.000 description 1
• 210000004351 coronary vessel Anatomy 0.000 description 1
• 108010068597 corticostatin Proteins 0.000 description 1
• ZKALIGRYJXFMNS-XBDDSDALSA-N corticostatin Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C(C)C)C(C)C)CC1=CC=CC=C1 ZKALIGRYJXFMNS-XBDDSDALSA-N 0.000 description 1
• 239000013078 crystal Substances 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• 108010066070 cysteinyl-prolyl-isoleucyl-glutamyl-aspartyl-arginyl-prolyl-methionyl-cysteine (1-9) disulfide Proteins 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 235000014103 egg white Nutrition 0.000 description 1
• 210000000969 egg white Anatomy 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 108700004025 env Genes Proteins 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 210000000267 erythroid cell Anatomy 0.000 description 1
• 210000003013 erythroid precursor cell Anatomy 0.000 description 1
• 102000015694 estrogen receptors Human genes 0.000 description 1
• 108010038795 estrogen receptors Proteins 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 210000003414 extremity Anatomy 0.000 description 1
• 229940012426 factor x Drugs 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 229940029303 fibroblast growth factor-1 Drugs 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 238000010363 gene targeting Methods 0.000 description 1
• 230000009395 genetic defect Effects 0.000 description 1
• 208000016361 genetic disease Diseases 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 230000002518 glial effect Effects 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 210000002149 gonad Anatomy 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000018706 hematopoietic system disease Diseases 0.000 description 1
• 208000005252 hepatitis A Diseases 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
• 229940022353 herceptin Drugs 0.000 description 1
• 238000012165 high-throughput sequencing Methods 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 108010046019 histidyl-glutamyl-tryptophyl-seryl-tyrosyl-leucyl-alanyl-prolyl-tyrosyl-prolyl-tryptophyl-phenylalanine Proteins 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 230000008676 import Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940028885 interleukin-4 Drugs 0.000 description 1
• 210000000936 intestine Anatomy 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 108010075476 isoleucyl-glutamyl-leucyl-leucyl-glutaminyl-alanyl-arginine Proteins 0.000 description 1
• 238000012804 iterative process Methods 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 229940039781 leptin Drugs 0.000 description 1
• NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
• URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical compound C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000003141 lower extremity Anatomy 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 229960000274 lysozyme Drugs 0.000 description 1
• 239000004325 lysozyme Substances 0.000 description 1
• 235000010335 lysozyme Nutrition 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 208000024393 maple syrup urine disease Diseases 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 108091061970 miR-26a stem-loop Proteins 0.000 description 1
• 108091070501 miRNA Proteins 0.000 description 1
• 239000002679 microRNA Substances 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 235000021243 milk fat Nutrition 0.000 description 1
• 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
• 229940051875 mucins Drugs 0.000 description 1
• 201000006417 multiple sclerosis Diseases 0.000 description 1
• 208000010805 mumps infectious disease Diseases 0.000 description 1
• 201000000585 muscular atrophy Diseases 0.000 description 1
• 201000006938 muscular dystrophy Diseases 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 229950006780 n-acetylglucosamine Drugs 0.000 description 1
• 230000010807 negative regulation of binding Effects 0.000 description 1
• 210000003061 neural cell Anatomy 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 101800000607 p15 Proteins 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 239000008194 pharmaceutical composition Substances 0.000 description 1
• 239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
• 230000000704 physical effect Effects 0.000 description 1
• 108010012604 pneumadin Proteins 0.000 description 1
• 108700004029 pol Genes Proteins 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 230000002516 postimmunization Effects 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 108010043277 recombinant soluble CD4 Proteins 0.000 description 1
• 238000009256 replacement therapy Methods 0.000 description 1
• 230000002207 retinal effect Effects 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 201000005404 rubella Diseases 0.000 description 1
• 229940043230 sarcosine Drugs 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 125000005629 sialic acid group Chemical group 0.000 description 1
• 239000002924 silencing RNA Substances 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 239000004055 small Interfering RNA Substances 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 201000003624 spinocerebellar ataxia type 1 Diseases 0.000 description 1
• 210000001324 spliceosome Anatomy 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 101150047061 tag-72 gene Proteins 0.000 description 1
• 229940118376 tetanus toxin Drugs 0.000 description 1
• YSMODUONRAFBET-WHFBIAKZSA-N threo-5-hydroxy-L-lysine Chemical compound NC[C@@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-WHFBIAKZSA-N 0.000 description 1
• 230000002992 thymic effect Effects 0.000 description 1
• 208000008732 thymoma Diseases 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000011820 transgenic animal model Methods 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 230000005740 tumor formation Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 239000002525 vasculotropin inhibitor Substances 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 229940051021 yellow-fever virus Drugs 0.000 description 1
• LYTCVQQGCSNFJU-LKGYBJPKSA-N α-bungarotoxin Chemical compound C(/[C@H]1O[C@H]2C[C@H]3O[C@@H](CC(=C)C=O)C[C@H](O)[C@]3(C)O[C@@H]2C[C@@H]1O[C@@H]1C2)=C/C[C@]1(C)O[C@H]1[C@@]2(C)O[C@]2(C)CC[C@@H]3O[C@@H]4C[C@]5(C)O[C@@H]6C(C)=CC(=O)O[C@H]6C[C@H]5O[C@H]4C[C@@H](C)[C@H]3O[C@H]2C1 LYTCVQQGCSNFJU-LKGYBJPKSA-N 0.000 description 1